Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Kymera Therapeutics, Inc.(KYMR) | 5,502,710 | 5,502,710 | 0 | $240.14M | $311.45M | 12.63% | +$71.32M |
| Revolution Medicines, Inc.(RVMD) | 4,982,384 | 3,974,913 | -1,007,471 | $183.30M | $185.63M | 7.52% | +$2.33M |
| Protagonist Therapeutics Inc | 3,211,041 | 2,560,916 | -650,125 | $177.47M | $170.12M | 6.90% | -$7.35M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 19,751,284 | 19,751,284 | 0 | $932.26M | $141.62M | 5.74% | -$790.64M |
| Cidara Therapeutics Inc | 786,392 | 1,414,165 | +627,773 | $38.31M | $135.42M | 5.49% | +$97.12M |
| GH Research PLC(GHRS) | 8,827,712 | 8,827,712 | 0 | $107.61M | $126.24M | 5.12% | +$18.63M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 2,761,333 | 1,495,290 | -1,266,043 | $140.52M | $109.62M | 4.44% | -$30.90M |
| Xoma Royalty Corporation | 2,590,303 | 2,590,303 | 0 | $65.28M | $99.83M | 4.05% | +$34.55M |
| Structure Therapeutics IncADS | 1,771,417 | 3,203,917 | +1,432,500 | $36.74M | $89.71M | 3.64% | +$52.97M |
| Kura Oncology, Inc.(KURA) | 7,754,129 | 8,617,162 | +863,033 | $44.74M | $76.26M | 3.09% | +$31.52M |
| Septerna, Inc.(SEPN) | 4,396,124 | 4,015,790 | -380,334 | $46.47M | $75.54M | 3.06% | +$29.07M |
| Palvella Therapeutics, Inc.(PVLA) | 696,555 | 1,161,249 | +464,694 | $15.70M | $72.80M | 2.95% | +$57.10M |
| Nektar Therapeutics(NKTR) | 0 | 1,276,595 | +1,276,595 | $0 | $72.64M | 2.94% | +$72.64M |
| Zymeworks Inc.(ZYME) | 4,308,935 | 3,938,641 | -370,294 | $54.08M | $67.27M | 2.73% | +$13.19M |
| Axsome Therapeutics, Inc.(AXSM) | 1,690,221 | 486,757 | -1,203,464 | $176.44M | $59.12M | 2.40% | -$117.33M |
| AC Immune SASHS(ACIU) | 19,822,436 | 19,822,436 | 0 | $40.24M | $57.29M | 2.32% | +$17.05M |
| Immunocore Holdings plcADS(IMCR) | 1,024,288 | 1,574,288 | +550,000 | $32.14M | $57.19M | 2.32% | +$25.05M |
| Olema Pharmaceuticals, Inc.(OLMA) | 5,295,893 | 5,295,893 | 0 | $22.56M | $51.85M | 2.10% | +$29.29M |
| Tyra Biosciences, Inc.(TYRA) | 3,944,194 | 3,649,794 | -294,400 | $37.75M | $51.06M | 2.07% | +$13.31M |
| ABIVAX Société AnonymeADS(ABVX) | 0 | 558,031 | +558,031 | $0 | $47.38M | 1.92% | +$47.38M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 5,660,132 | 5,660,132 | 0 | $25.53M | $41.94M | 1.70% | +$16.41M |
| 4d Molecular Therapeutics In | 4,629,289 | 4,629,289 | 0 | $17.17M | $40.23M | 1.63% | +$23.05M |
| Stoke Therapeutics, Inc.(STOK) | 0 | 1,657,096 | +1,657,096 | $0 | $38.94M | 1.58% | +$38.94M |
| Cullinan Therapeutics, Inc.(CGEM) | 5,750,683 | 5,750,683 | 0 | $43.30M | $34.10M | 1.38% | -$9.20M |
| Celcuity Inc.(CELC) | 3,466,000 | 658,421 | -2,807,579 | $46.27M | $32.53M | 1.32% | -$13.75M |
| Xencor, Inc.(XNCR) | 2,740,141 | 2,740,141 | 0 | $21.54M | $32.14M | 1.30% | +$10.60M |
| Foghorn Therapeutics Inc.(FHTX) | 5,302,000 | 5,302,000 | 0 | $24.92M | $25.93M | 1.05% | +$1.01M |
| Annexon, Inc.(ANNX) | 7,000,000 | 7,000,000 | 0 | $16.80M | $21.35M | 0.87% | +$4.55M |
| Repare Therapeutics Inc | 10,333,600 | 10,333,600 | 0 | $14.36M | $18.19M | 0.74% | +$3.82M |
| Avalo Therapeutics, Inc.(AVTX) | 1,028,049 | 1,355,256 | +327,207 | $5.13M | $17.23M | 0.70% | +$12.10M |
| Compass Therapeutics, Inc.(CMPX) | 0 | 4,750,000 | +4,750,000 | $0 | $16.63M | 0.67% | +$16.63M |
| Crescent Biopharma, Inc.(CBIO) | 1,387,863 | 1,387,863 | 0 | $22.40M | $16.50M | 0.67% | -$5.90M |
| Eledon Pharmaceuticals, Inc.(ELDN) | 6,293,282 | 6,293,282 | 0 | $17.05M | $16.30M | 0.66% | -$755.2K |
| TScan Therapeutics, Inc.(TCRX) | 5,226,074 | 5,226,074 | 0 | $7.58M | $9.51M | 0.39% | +$1.93M |
| PepGen Inc.(PEPG) | 0 | 1,915,000 | +1,915,000 | $0 | $8.85M | 0.36% | +$8.85M |
| X4 Pharmaceuticals, Inc.(XFOR) | 0 | 2,233,742 | +2,233,742 | $0 | $7.64M | 0.31% | +$7.64M |
| Immunic, Inc.(IMUX) | 7,652,972 | 7,652,972 | 0 | $5.34M | $6.75M | 0.27% | +$1.41M |
| ImageneBio, Inc.(IMA) | 0 | 802,102 | +802,102 | $0 | $6.54M | 0.26% | +$6.54M |
| Molecular Partners AGADS(MOLN) | 1,353,968 | 1,353,968 | 0 | $5.19M | $5.02M | 0.20% | -$162.5K |
| Inventiva S.A.ADS(IVA) | 686,040 | 686,040 | 0 | $2.14M | $3.97M | 0.16% | +$1.83M |
| Tenax Therapeutics, Inc.(TENX) | 339,549 | 339,549 | 0 | $1.98M | $2.58M | 0.10% | +$601.0K |
| Essa Pharma Inc | 8,748,629 | 11,668,473 | +2,919,844 | $14.87M | $2.23M | 0.09% | -$12.64M |
| SAB Biotherapeutics, Inc.(SABS) | 917,826 | 932,697 | +14,871 | $1.61M | $1.87M | 0.08% | +$268.5K |
| Forte Biosciences Inc | 588,344 | 65,350 | -522,994 | $7.61M | $980.3K | 0.04% | -$6.63M |
| Engene Holdings IncW EXP 10 31 202 *W EXP 10/31/202 | 945,402 | 945,402 | 0 | $586.1K | $680.7K | 0.03% | +$94.5K |
| Nls Pharmaceutics Ltd | 143,676 | 143,676 | 0 | $416.7K | $262.9K | 0.01% | -$153.7K |
| Ikena Oncology Inc | 4,006,564 | 0 | -4,006,564 | $5.37M | $0 | — | -$5.37M |
| Ionis Pharmaceuticals, Inc.(IONS) | 1,913,385 | 0 | -1,913,385 | $75.60M | $0 | — | -$75.60M |
| Ovid Therapeutics Inc.(OVID) | 3,853,818 | 0 | -3,853,818 | $1.27M | $0 | — | -$1.27M |
| Rapt Therapeutics Inc | 1,154,692 | 0 | -1,154,692 | $9.24M | $0 | — | -$9.24M |
| Verastem, Inc.(VSTM) | 3,404,425 | 0 | -3,404,425 | $14.13M | $0 | — | -$14.13M |